Real-world safety of terlipressin in elderly patients with liver cirrhosis and esophagogastric variceal bleeding: a focus on hyponatremia and administration methods
{{output}}
Introduction: Terlipressin is a first-line vasoactive agent for esophageal and gastric variceal bleeding (EGVB) in patients with liver cirrhosis, typically administered alongside proton pump inhibitors as background acid-suppress... ...